A Follow-up Evaluation Study of PRI-724-1101
NCT02828254
·
clinicaltrials.gov ↗
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C Virus-infected Cirrhosis
Interventions
DRUG:
PRI-724
Sponsor
Komagome Hospital
Collaborators
[object Object]
[object Object]